SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-001284
Filing Date
2022-02-15
Accepted
2022-02-15 16:19:35
Documents
106
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rare-20211231.htm   iXBRL 10-K 4869629
2 EX-10.13 rare-ex10_13.htm EX-10.13 60536
3 EX-10.20 rare-ex10_20.htm EX-10.20 30627
4 EX-21.1 rare-ex21_1.htm EX-21.1 21050
5 EX-23.1 rare-ex23_1.htm EX-23.1 7357
6 EX-31.1 rare-ex31_1.htm EX-31.1 18129
7 EX-31.2 rare-ex31_2.htm EX-31.2 18128
8 EX-32.1 rare-ex32_1.htm EX-32.1 14076
9 GRAPHIC img196301111_0.jpg GRAPHIC 23046
10 GRAPHIC img214107015_0.jpg GRAPHIC 200411
11 GRAPHIC img214107015_1.jpg GRAPHIC 172506
  Complete submission text file 0000950170-22-001284.txt   18379698

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20211231.xsd EX-101.SCH 104793
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20211231_pre.xml EX-101.PRE 562593
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20211231_lab.xml EX-101.LAB 745143
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20211231_cal.xml EX-101.CAL 94986
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20211231_def.xml EX-101.DEF 319702
100 EXTRACTED XBRL INSTANCE DOCUMENT rare-20211231_htm.xml XML 3836984
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36276 | Film No.: 22639426
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences